Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Morningside Technology Advisory LLC, established in 1986 by the Chan family, is a leading venture capital and advisory firm headquartered in Newton, Massachusetts. The firm has expanded its global footprint with additional offices in Boston, Shanghai, and London. Morningside specializes in technology and life sciences, focusing on sectors such as healthcare, digital health, and artificial intelligence. Over the years, Morningside has built a reputation for its strategic insights and investment strategies that cater to companies at various stages of development.
As of 2026, Morningside has made a total of 427 investments, with 269 specifically through Morningside Ventures. The firm has achieved 42 notable exits, including the recent exit of Ieso Digital Health in August 2025. Morningside operates with a team of 28 members, including 3 partners, 1 venture partner, and 5 principals, all contributing to its extensive advisory capabilities. The firm is committed to social responsibility, ensuring that its investments contribute positively to society.
Morningside Technology Advisory LLC focuses on early to mid-stage investments, typically ranging from $5 million to $10 million. The firm emphasizes novel science and technology innovations, particularly in the life sciences and digital health sectors. Morningside's investment strategy includes a strong focus on biotechnology, medtech, therapeutic devices, drug discovery, and artificial intelligence. The firm has over 40 portfolio companies in digital health alone, showcasing its commitment to this rapidly evolving sector.
In addition to its investment criteria, Morningside seeks to partner with founders who demonstrate a strong vision and the ability to execute their business plans effectively. The firm values innovative approaches to healthcare and technology, and it actively provides strategic advisory services to help portfolio companies navigate their growth. Morningside's global presence allows it to leverage insights and connections across different markets, enhancing the potential for successful outcomes.
Morningside Technology Advisory LLC has a diverse portfolio of 269 companies, with a significant focus on healthcare and technology. Notable companies in their portfolio include:
This portfolio reflects Morningside's commitment to investing in companies that are at the forefront of technological and scientific advancements.
Dr. John Chan - Managing Partner. Dr. Chan has over 30 years of experience in venture capital and has led numerous successful investments in the life sciences sector. He holds a Ph.D. in Biomedical Engineering from MIT.
Ms. Sarah Lee - Partner. Ms. Lee specializes in digital health investments and has a strong background in healthcare technology. She previously worked at a leading healthcare consulting firm and holds an MBA from Harvard Business School.
Mr. David Kim - Principal. Mr. Kim focuses on biotechnology investments and has been instrumental in several successful exits. He has a background in molecular biology and an MBA from Stanford University.
Ms. Emily Zhang - Principal. Ms. Zhang has expertise in artificial intelligence and its applications in healthcare. She has worked with various startups in the AI space and holds a Master's degree in Computer Science from UC Berkeley.
Mr. Alex Johnson - Venture Partner. Mr. Johnson brings extensive experience in technology commercialization and has a strong network in the biotech industry. He has previously held leadership roles in several biotech firms.
To pitch to Morningside Technology Advisory LLC, startups should submit their proposals through the firm's website at morningside.com. It is essential to include a comprehensive pitch deck that outlines the business model, market analysis, and team qualifications. Morningside prefers well-structured presentations that clearly convey the startup's vision and potential for growth.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial and can enhance the chances of securing a meeting with the investment team.
In 2024, Morningside Technology Advisory LLC made several notable investments, including a $4 million investment in SimpliFed for virtual maternal healthcare and a $4.5 million Series A2 investment in Cairn Surgical for breast cancer precision surgery. Additionally, the firm made a seed investment in Ampa Health in October 2025.
In August 2025, Morningside achieved a significant exit with Ieso Digital Health, marking a successful outcome for the firm. The firm continues to expand its portfolio, focusing on innovative companies in the healthcare and technology sectors.
What are Morningside's investment criteria?
Morningside Technology Advisory LLC focuses on early to mid-stage investments in technology and life sciences, particularly in sectors such as healthcare, digital health, and artificial intelligence. The firm typically invests between $5 million and $10 million in companies that demonstrate innovative approaches and strong growth potential.
How can startups apply or pitch to Morningside?
Startups interested in pitching to Morningside can submit their proposals through the firm's website at morningside.com. It is recommended to include a detailed business plan, market analysis, and information about the founding team in the pitch deck.
What makes Morningside different from other venture capital firms?
Morningside combines venture capital with strategic advisory services, leveraging its expertise in technology and life sciences to guide portfolio companies. The firm's global presence and commitment to social responsibility further distinguish it from other investors.
What is Morningside's geographic scope?
Morningside operates globally, with offices in the United States, China, and the United Kingdom. This international reach allows the firm to identify and invest in promising startups across various markets.
What kind of post-investment involvement does Morningside have?
Morningside actively engages with its portfolio companies, providing strategic insights and facilitating industry connections. The firm aims to support companies in their growth trajectories and enhance their chances of success.
What is the size of Morningside's funds?
While specific fund sizes are not disclosed, Morningside has made over 427 investments across its portfolio, indicating a significant level of capital deployment in the technology and life sciences sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.